Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Heilongjiang Wuzun Pharmaceutical is a Chinese pharmaceutical company primarily engaged in the research, development, production, and sale of Traditional Chinese Medicine (TCM) and chemical drug formulations. The company operates a large-scale manufacturing facility in Heilongjiang Province, focusing on therapeutic areas such as cardiovascular health, respiratory conditions, and anti-inflammatory treatments. Its product portfolio includes various dosage forms such as injections, capsules, and tablets, with a significant emphasis on modernized TCM preparations. Wuzun Pharmaceutical serves the domestic Chinese market, adhering to national Good Manufacturing Practice (GMP) standards to ensure product quality and safety.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Heilongjiang Wuzun Pharmaceutical.